Dr. Graham Michael Lohrmann, MBCHB, MD

Dr. Lohrmann practices at Essentia Health St. Mary's Heart and Vascular Center in Duluth, Minnesota.

Dr. Lohrmann's NPI, 1285003178, was assigned on September 21, 2015. Dr. Lohrmann holds Minnesota license 76310.

Dr. Lohrmann's primary practice is Essentia Health St. Mary's Heart and Vascular Center, at 420 E 1st St, Duluth, MN 55805 in Saint Louis County. The practice phone is (218) 786-3443.

Dr. Lohrmann's primary practice is Essentia Health St. Mary's Heart and Vascular Center in Duluth, Minnesota. Dr. Lohrmann is also affiliated with Essentia Health-Duluth (Miller-Dwan, Building D). The medical group on file is Essentia Health-Duluth Clinic. Dmand AI also links Dr. Lohrmann to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lohrmann practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Lohrmann's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Lohrmann's licenses on file in 4 states: Minnesota, Illinois, Massachusetts and Wisconsin.

CMS data shows 233 Medicare services from Dr. Lohrmann across 7 procedure codes in 2024, for 235 Medicare patients. Medicare paid $9,907 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 235 Medicare patients who saw Dr. Lohrmann in 2024. The largest group is 75 to 84, with 97 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lohrmann's median patient age at 74, with 46% women.

In 2024, Dr. Lohrmann wrote 68 Medicare Part D claims for 38 patients. 91% of them were for generic drugs. CMS names the drug for 36 of them, across 2 drugs with 11 or more claims each, at $663 in total drug cost. In 2022, CMS named 51 claims across 3 drugs.

Dr. Lohrmann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lohrmann as offering telehealth. CMS counts 47 procedures of pacemaker insertion or repair by Dr. Lohrmann, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 18 papers to Dr. Lohrmann, published from 2014 to 2024. 2024 was the busiest year, with 4. The most frequent topics are Catheter Ablation, Predictive Value of Tests and Action Potentials. Dr. Lohrmann has published most often in J Cardiovasc Electrophysiol. Dr. Lohrmann's most frequent co-authors are Rishi Arora, MD, Susan S. Kim, MD and Albert C. Lin, MD.

CMS Open Payments shows 245 general payments to Dr. Lohrmann from 14 drug and device companies from 2019 to 2025. Grants make up the largest share, 60% of the total. Abbott Laboratories paid the most, $17,091.